Regeneron Pharmaceuticals, Inc. (REGN)
785.51
+18.88
(+2.46%)
USD |
NASDAQ |
Feb 06, 16:00
784.85
-0.66
(-0.08%)
After-Hours: 20:00
Regeneron Pharmaceuticals Shareholders Equity (Quarterly) : 31.26B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 8.658B |
| Gilead Sciences, Inc. | 21.54B |
| Johnson & Johnson | -- |
| Eli Lilly & Co. | -- |
| Merck & Co., Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.56B |
| Total Liabilities (Quarterly) | 9.302B |
| Debt to Equity Ratio | 0.0951 |
| Current Ratio | 4.126 |
| Net Debt Paydown Yield | -0.07% |